# Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

> **NCT02499458** · — · COMPLETED · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 44 (actual)

## Conditions studied

- Clear Cell Renal Cancer
- Circulating Tumor Cells
- Circulating Endothelial Cells
- Prognostic Biomarkers
- Predictive Biomarkers

## Interventions

- **OTHER:** None- observational study

## Key facts

- **NCT ID:** NCT02499458
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2018-12
- **Final completion:** 2018-12
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2019-12-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02499458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02499458, "Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02499458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*